EBOS cancels $3.75 billion Greencross purchase in surprise twist
Business media and market chatter had the New Zealand pharmaceutical and animal products giant, EBOS (ASX:EBO), poised to finalise a $3.75 billion acquisition of the Greencross animal care group. The Financial Review boldly stated, “Trans-Tasman pharma distributor EBOS will pay $3.75 billion to acquire TPG Capital-backed pets and vets business Greencross, details of which were […]
EBOS cancels $3.75 billion Greencross purchase in surprise twist Read More »